ImmuPharma (LON:IMM) Trading 22.9% Higher – Here’s What Happened

by · The Markets Daily

ImmuPharma plc (LON:IMM – Get Free Report) rose 22.9% during trading on Friday . The company traded as high as GBX 4.70 ($0.06) and last traded at GBX 4.30 ($0.05). Approximately 64,504,590 shares traded hands during mid-day trading, an increase of 155% from the average daily volume of 25,253,549 shares. The stock had previously closed at GBX 3.50 ($0.04).

ImmuPharma Stock Up 14.3 %

The firm has a fifty day moving average price of GBX 1.40 and a two-hundred day moving average price of GBX 1.65. The stock has a market capitalization of £16.66 million, a P/E ratio of -400.00 and a beta of 1.53.

ImmuPharma Company Profile

(Get Free Report)

ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity and inflammation, and anti-infectives. The company's lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease.

Featured Stories